CDKN2A and pachyonychia congenita: Key mutations detected in PC involve the proto-oncogene KRAS and the tumor suppressors CDKN2A, TP53, and SMAD4/DPC4, which are associated with cell cycle deregulation, apoptosis inhibition, invasion, metastasis, and poor treatment outcomes [5].